STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3012 by analyst upside · 2026-08-12
DOC
Healthpeak Properties, Inc.
Real Estate · Market Cap $15B · P/E 58.6x
ANALYST PRICE TARGET
+11.5%
implied upside to consensus target
Current Price $20.51
Consensus Target $22.87
Bull Target $29.0
Bear Target $17.0
Analysts Covering 19
ANALYST CONSENSUS - BUY
Strong Buy
3
Buy
4
Hold
12
Sell
0
52-Week Low $15.7
52-Week High $22.95
YTD Return +31.6%
FUNDAMENTALS
Market Cap $15B
P/E Ratio (TTM) 58.6x
Forward P/E N/A
EPS (TTM) $0.35
PEG Ratio 4.32
Dividend Yield 5.84%
Revenue (TTM) $2.9B
Profit Margin 8.2%
52-WEEK RANGE
52-Week Low $15.7
52-Week High $22.95
Current Price $20.51
Bear Target $17.0
Bull Target $29.0
● Now $20.51 ● Target $22.87
TRADING DATA
Avg Volume 7.7M
YTD Return +31.6%
Analyst Count 19
Consensus Buy
Upside to Target +11.5%
Last Updated 2026-08-12

ANALYST SUMMARY

Healthpeak Properties, Inc. (DOC) is currently trading at $20.51 with a Wall Street consensus price target of $22.87, implying potential upside of 11.5% over the next 12 months. 19 analysts currently cover DOC, with a consensus rating of Buy - 37% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $29.0, while the most cautious has a target of $17.0.

DOC operates in the Real Estate sector with a market capitalisation of $15B. The stock is up 31.6% year-to-date and is currently trading near the upper end of its 52-week range of $15.7 – $22.95.

SIMILAR STOCKS

Other Real Estate stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for DOC, with each firm's 90-day track record across all stocks we track. See full firm rankings →

BMO Capital - Reiterated
Outperform → Outperform 2026-06-15 Building track record
Morgan Stanley ↓ Downgrade
Overweight → Equal-Weight 2026-06-11 Building track record
Wells Fargo - Reiterated
Equal-Weight → Equal-Weight 2026-06-01 Building track record
Scotiabank - Reiterated
Sector Perform → Sector Perform 2026-05-27 20% win rate (5 calls)
Morgan Stanley - Reiterated
Overweight → Overweight 2026-05-22 Building track record
RBC Capital - Reiterated
Outperform → Outperform 2026-05-14 Building track record
UBS - Reiterated
Neutral → Neutral 2026-05-13 33% win rate (6 calls)
Baird - Reiterated
Outperform → Outperform 2026-05-13 Building track record
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
43
out of 100
Coverage depth
23/30
Consensus clarity
18/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →